Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin 10mg Once Daily (XATRAL 10mg OD), Open, 24-Week Study
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2009
At a glance
- Drugs Alfuzosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- Acronyms SAMBA-Thailand
- Sponsors Sanofi
- 07 Jul 2008 The actual end date is Dec 2007 as reported by ClinicalTrials.gov.
- 07 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 25 Jun 2008 New trial record.